Delivery Order SPE2DB20D9153-SPE2DB25FF20P

Award Date 2/14/25
Potential Completion Date 3/10/25
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,536.45 firm fixed-price delivery order contract covers the provision of 4567099426 ! LIVDELZI 10 MG CAPSULE 30S, a pharmaceutical product, with a completion date of February 18, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, with a value of $19,072.90, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4567099452 ! LIVDELZI 10 MG CAPSULE 30S, a specialized pharmaceutical product. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $19,072.90 firm fixed-price delivery order is for the supply of the prescription drug "LIVDELZI 10 MG CAPSULE 30S" and does not have a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,536.45 firm fixed-price delivery order is for the provision of LIVDELZI 10 MG CAPSULE 30S, a specialized pharmaceutical product, with a period of performance through January 22, 2025. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) valued at $499,999,999 with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract, valued at $28,609.35, is for the delivery of 4567099428 ! LIVDELZI 10 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through February 19, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This federal contract award, with the ID SPE2DX15D9114|SPE2DX25F5ZKG, was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $28,609.35 firm fixed-price delivery order is for the supply of LIVDELZI 10 MG CAPSULE 30S, a pharmaceutical product, with a completion date of December 10, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) awarded a $25,397.84 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which runs through December 31, 2025. Under this vehicle, DMS Pharmaceutical Group provides a wide range of pharmaceutical products,...
The U.S. government agency, Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract valued at $77,070.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, awarded under the DLA's SPE2DB program, covers the delivery of a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $15,105.30, is for the provision of a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities and VA medical centers nationwide. This delivery order is part of a larger indefinite delivery...
The U.S. government's Defense Logistics Agency (DLA) awarded a Delivery Order contract, valued at $80,285.70, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This Delivery Order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $499,999,999, which provides a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The contract...
  • SPE2DB20D9153
    Indefinite Delivery Contract
  • SPE2DB20D9153-SPE2DB25FF20P
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $19,072.90 firm fixed-price delivery order is for the supply of 4567316734 ! LIVDELZI 10 MG CAPSULE 30S, with an ultimate completion date of March 10, 2025.

DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently demonstrated its capability to provide a diverse array of pharmaceutical products to the DLA through its federal contract awards.

Generated 5/16/25, 11:55 AM